Zolmitriptan nasal spray in the acute treatment of cluster headache: A double-blind study

Neurology

Volumn 69, Issue 9, 2007, Pages 821-826

  Rapoport, A M ^a,b,h   Mathew, N T ^c   Silberstein, S D ^d   Dodick, D ^e   Tepper, S J ^b,f   Sheftell, F D ^b   Bigal, M E ^b,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c Houston Headache Clinic   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e MAYO CLINIC   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; LIDOCAINE; PLACEBO; SUMATRIPTAN; ZOLMITRIPTAN;

ANALGESIA; ARTICLE; CHEST TIGHTNESS; CLINICAL TRIAL; CLUSTER HEADACHE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NOSE CAVITY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; THROAT TIGHTNESS;

ACUTE DISEASE; ADMINISTRATION, INTRANASAL; ADULT; AGED; CLUSTER HEADACHE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; PLACEBO EFFECT; SEROTONIN AGONISTS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 34548258794     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000267886.85210.37     Document Type: Article

References (20)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Second edition. Cephalalgia 2004; (suppl 1):1-160.
2. Goadsby PJ. Trigeminal autonomic cephalalgias: pathophysiology and classification. Rev Neurol (Paris) 2005;161:692-695.
3. Sjastaad O, Bakketeig LS. Cluster headache prevalence: Vaga study of headache epidemiology. Cephalalgia 2003;23:528-533.
4. Ekbom K, Svensson DA, Pedersen NL, Waldenlind E. Lifetime prevalence and concordance risk of cluster headache in the Swedish twin population. Neurology 2006;67:798-803.
5. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D'Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 2004;25 (suppl 3):S105-S107.
6. Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Cluster headache. Cephalalgia 2000;20:787-803.
7. Ekbom K, The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991;325:322-326.
8. Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache 1981;21:1-4.
9. Robbins L. Intranasal lidocaine for cluster headache. Headache 1995;35:83-84.
10. Andersson PG, Jespersen LT. Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. Cephalalgia 1986;6:51-54.
11. Rapoport AM, Ramadan NM, Adelman JU, Mathew NT, Elkind AH, Kudrow DB, Earl NL. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine: a multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group. Neurology 1997;49:1210-1218.
12. Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD. Intranasal medications for the treatment of migraine and cluster headache. CNS Drugs 2004;18:671-685.
13. Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Farkkila M. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. CNS Drugs 2003;17:653-667.
14. Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS Drugs 2005;19:125-136.
15. VanVliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache: a randomized placebo-controlled double-blind study. Neurology 2003;60:630-633.
16. Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006;63:1537-1542.
17. Lipton RB, Micieli G, Russell D, Solomon S, Tfelt-Hansen P, Waldenlind E. Guidelines for controlled trials of drugs in cluster headache. Cephalalgia 1995;15:452-462.
18. Dworkin RH, Katz J, Gitlin MJ. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology 2005;65 (suppl 4):S7-S19.
19. Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology 2005;65 (suppl 4):S50-S58.
20. Tepper SJ, Rapoport AM, Sheftell FD. Ethical considerations in cluster headache research. Curr Pain Headache Reports 2002;6:47-51.